WET AMD JOURNEY
- At his annual ophthalmology appointment, Randall was concerned about a decrease in his vision.
- Randall’s imaging led to a diagnosis of predominantly classic subfoveal CNV due to AMD.
- Randall was on an anti-VEGF injection regimen for 1.5 years, with an improvement in visual acuity from 20/160 to 20/40.
- Despite anti-VEGF treatment, residual subretinal fluid remained.
- As a patient who was still experiencing persistent fluid, Randall could benefit from another wet AMD therapy option.
- Randall was given VISUDYNE® to help resolve his persistent retinal fluid and maintain his vision.1,2
AMD=age-related macular degeneration, anti-VEGF=anti-vascular endothelial growth factor, CNV=choroidal neovascularization, SD-OCT=spectral domain optical coherence tomography.